AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-Health and Human Services Appropriations and asked for additional Food and Drug Administration (FDA) funding. Letter to NIOSH (CDC) on E-health records.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare program, outpatient hospital payment, Part D, and Conditions of Participation regarding single use vials of drugs and drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
S. 3187, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.